Vaccines-2013 - OMICS Group

Recommendations

Info

November3 rd World Congress onVirologyTheme: “Exploring Novel Approaches in Virology”3 rd World Congress on Virology serves as a meeting ground for scientists in the broad areas of viral infections, preventive andtherapeutic modalities. This conference aims to bring together academic scientists, leading engineers, industry researchers and scholarstudents to exchange and share their experiences, research results about all aspects of virology and viral diseases, and discuss thepractical challenges encountered and the solutions adopted.www.omicsgroup.com/conferences/virology-2013Scientific TracksTrack 1: Modern Approaches in Viral ScienceTrack 1-1 General viral scienceTrack 1-2 Viral genetics and transmissionTrack 1-3 Genomics and proteomics of virusesTrack 1-4 Viral replication mechanismsTrack 2: Viral Breakout Prevention and MeasuresTrack 2-1 New strategies for anti-viral agentsTrack 2-2 Viral threat breakout, prediction, and measuresTrack 2-3 Epidemiology of emerging virusesTrack 2-4 Prevention and measures to curb viral breakoutsTrack 2-5 Viral evolutionTrack 3: Human Viral Diseases Affecting Afro-Asian ContinentsTrack 3-1 Human papilloma virusTrack 3-2 RabiesTrack 3-3 RubellaTrack 3-4 Mumps and measlesTrack 3-5 Japanese encephalitisTrack 3-6 RotavirusTrack 3-7 Hand, foot and mouth diseasesTrack 3-8 Combating viral diseases in Afro-Asian continentsTrack 4: HIV and other Retroviral Diseases Affecting Afro-Asian ContinentsTrack 4-1 Systems biology in HIV, METH and cARTTrack 4-2 HIV diagnosisTrack 4-3 HIV and retroviral transmission and preventionTrack 4-4 Anti-retroviral therapies and associated complicationsTrack 4-5 Psychological and social issues associated with HIVTrack 4-6 Opportunistic diseases in HIVTrack 4-7 Immunology of HIV and retroviral infectionsTrack 4-8 Clinical trials in HIV/AIDSTrack 4-9 Nucleoside analoguesTrack 4-10 HIV vaccines and advancesTrack 4-11 Molecular mechanisms and novel targetsTrack 5: Organ Specific Cancers and Tumour VirologyTrack 5-1 Viral gastroenteritisTrack 5-2 Hepatocellular carcinomasTrack 5-3 HPV associated cervical cancersTrack 5-4 Human herpes virus and cancersTrack 5-5 Simian virus 40Track 5-6 Other cancer associated viral infectionsTrack 6: Respiratory and Vector Borne DiseasesTrack 6-1 Influenza A (H1N1)Track 6-2 Severe acute respiratory syndromeTrack 6-3 Avian flu (H5N1)Track 6-4 Dengue virusTrack 6-5 Hanta virusTrack 6-6 Ebola virusTrack 6-7 West Nile virusTrack 7: Therapeutic Approaches and Targets for Viral InfectionsTrack 7-1 DNA vaccinesTrack 7-2 Interleukin immune therapyTrack 7-3 Antibody therapy against virusesTrack 7-4 Gene therapy for viral infectionsTrack 7-5 Viral vaccinesTrack 7-6 Vaccine allergyTrack 7-7 Antiviral drugs and adjuvantsTrack 7-8 Safety evaluation of viral vaccinesTrack 7-9 Antigen presenting cell-targeted therapyVirology-2013161 st OMICS Group ConferenceDoubleTree by Hilton Baltimore-BWI Airport, MD, USA November 20-22, 2013Track 8: Viral HepatitisTrack 8-1 Hepatitis ATrack 8-2 Hepatitis BTrack 8-3 Hepatitis CTrack 8-4 Hepatitis DTrack 8-5 Hepatitis ETrack 8-6 Epidemiology of hepatitisTrack 8-7 Hepatitis virology and immunologyTrack 9: Viral ImmunologyTrack 9-1 Viral immune evasionTrack 9-2 Receptors and signallingTrack 9-3 Neutralizing antibodiesTrack 9-4 Adjuvants and cell-based immunityTrack 9-5 Prophylactic and therapeutic vaccinesTrack 10: Neurological Infections Associated with VirusesTrack 10-1 Neurological disorders by virusesTrack 10-2 Molecular diagnosis of nervous system virusesTrack 10-3 NeuropathogenesisTrack 10-4 AIDS associated neural diseasesTrack 11: Agriculture and Plant VirologyTrack 11-1 Plant virus epidemiology, ecology, and evolutionTrack 11-2 Viral vector biology and transmissionTrack 11-3 Wheat and rice virusesTrack 11-4 Vegetable virusesTrack 11-5 Tobacco virusTrack 11-6 Grape wine leaf roll diseaseTrack 11-7 Virus resistant plants and disease controlTrack 11-8 Biotechnology in plant viral diseasesTrack 11-9 Viral mediated plant transformationsTrack 12: Animal VirusesTrack 12-1 Zoonoses epidemiologyTrack 12-2 Viroid and prion diseasesTrack 12-3 Functional genomics and proteomics of animal virusesTrack 12-4 Animal vaccines and viral immunologyTrack 13: BacteriophagesTrack 13-1 Impact on bacterial genome evolutionTrack 13-2 Phage therapy and its applicationsTrack 13-3 Clinical trials in phage therapyTrack 13-4 Novel anti-phage mechanisms in bacteriaTrack 14: Recent Advances in Drug DiscoveryTrack 14-1 Bioinformatics in drug discoveryTrack 14-2 Drug-drug interactionsTrack 14-3 Lead targets in drug discoveryTrack 14-4 Antiviral drug resistanceTrack 15: Current Focus on Virology ResearchTrack 15-1 Stem cell therapy for viral infections: Promises and challengesTrack 15-2 New strategies to combat flu virusesTrack 15-3 Strain identification assays and rapid diagnostic testing for viral infectionsTrack 15-4 Clinical virologyTrack 15-5 Viruses and nanotechnologyVirology-2012 ReportThe 2 nd World Conference on Virology was held during August 20-22, 2012 in Las Vegas, USAhighlighting “Innovations and Therapeutic Approaches in Virology”.Virology-2012 was attended by about 200 delegates from across the globe. Eminent speakers gavetheir fruitful contributions at the conference including exhaustive poster presentations by young researchersand veterans. Moreover, workshops on NIH Grantsmanship and High Throughput Screening and AssayDevelopment were organized during the the conference. Simultaneously, Editorial Board Meeting and B2Bsessions between renowned scientists and individuals from business community took place.Page 20
Virology-2013OMICS Group is organizing Virology-2013 with the overwhelming support from more than 200 Editorial Board Members ofrelated journals, that includes Journal of Antivirals & Antiretrovirals, and Journal of Virology and Mycology.Marc HV Van RegenmortelDirectorCNRS, School of BiotechnologyUniversity of StrasbourgFranceSharof Tugizov MAssociate ProfessorUniversity of CaliforniaUSATel: 415-514-3177Fax: 415-476-9364Organizing Committee MembersJames MahonyAssistant Dean Medical Sciences, ProfessorDeptartment of Pathology & Molecular MedicineMcMaster UniversityUSATel: 905 522-1155Fax: 905 521-6083Junona MoroianuAssociate Professor of BiologyBoston CollegeUSATel 617-552-1713Deepak ShuklaProfessorUniversity of Illinois at ChicagoUSATel: 312-355-0908Aamir ShahzadSecretary General & Director of AdministrationInternational Society for Translational Medicine(ISTM)AustriaHye Kyung ChungSr. Staff ScientistABL, Inc.USATel: 301-816-5351Fax: 301-468-9466Hua ZhuAssociate ProfessorDepartment of Microbiology & Molecular GeneticsUniversity of Medicine & Dentistry of New JerseyUSATel 973-972-4483 x26488Aboul-Ata E Aboul-AtaPresidentArab Society for VirologyEgyptEeva TuppurainenHead of Capripoxvirus Reference laboratoryInstitute for Animal HealthUKDavid JansNMHRC Senior Principal Research FellowUniversity of MelbourneAustraliaSuresh MahalingamPrincipal Research LeaderEmerging Viruses and Institute for GlycomicsGriffith University, Gold Coast CampusAustraliaTel: 61-7-5552-7178Fax: 61-7-5552-8098NovemberEditorsJournal of Antivirals & AntiretroviralsJournal of AIDS & Clinical ResearchJournal of Virology and MycologyJoin your Peers @ Virology-2013• Are you interested in organizing a track?• Organizing a small symposium at this venue?• Organizing a small workshop at this conference?• Deliver a speech?• Present a poster/oral presentation?• Sponsor the event?• Exhibit at the event?• Participate in B2B meeting?Conference VenueDoubleTree by Hilton Baltimore- BWI Airport890 Elkridge Landing Road, Linthicum, MD 21090, USAPlease contact: virology2013@omicsonline.comwww.omicsgroup.com/conferences/virology-2013Hosting OrganizationOMICS Group Inc.2360 Corporate Circle, Suite 400, Henderson, NV 89074-7722, USAPhone: +1-888-843-8169, Fax: +1-650-618-1417Toll Free: +1-800-216-6499Email: contact.omics@omicsonline.orgPage 21
Page 1 and 2: 111 th OMICS Group ConferenceJuly 2
Page 3 and 4: Medical SciencesISSNAddiction Resea
Page 5 and 6: Impact Factors (IF) and Index Coper
Page 7 and 8: 111 th OMICS Group Conference3 rd I
Page 9 and 10: Journal of Clinical & Cellular Immu
Page 15 and 16: Clinical Microbiology-2013OMICS Gro
Page 17 and 18: Immunology Summit-2013OMICS Group i
Page 19: Probiotics-2013OMICS Group is organ
Page 25 and 26: Because of heightened awareness of
Page 33 and 34: Ara Hovanessian, J Vaccines Vaccin
Page 35 and 36: Nikolai Petrovsky, J Vaccines Vacci
Page 39 and 40: Robert E. Sievers et al., J Vaccine
Page 41 and 42: Xiao-Qing Wei, J Vaccines Vaccin 20
Page 43 and 44: Campbell Bunce, J Vaccines Vaccin 2
Page 45 and 46: Hong Xin, J Vaccines Vaccin 2013, 4
Page 47 and 48: Diane Longo et al., J Vaccines Vacc
Page 49 and 50: Track 33: Novel Approaches in Desig
Page 51 and 52: Takashi Kei Kishimoto, J Vaccines V
Page 53 and 54: Benjamin Petsch, J Vaccines Vaccin
Page 55 and 56: A. Bennett Jenson et al., J Vaccine
Page 57 and 58: Milan Raska et al., J Vaccines Vacc
Page 59 and 60: Muhammad Ali A. Shah et al., J Vacc
Page 61 and 62: Track 44: Vaccines against Infectio
Page 63 and 64: Haval Shirwan, J Vaccines Vaccin 20
Page 65 and 66: Rainer Fischer, J Vaccines Vaccin 2
Page 67 and 68: Alwyn Rapose, J Vaccines Vaccin 201
Page 69 and 70: Saroj Basak, J Vaccines Vaccin 2013
Page 71 and 72:
Gisela Gonzalez, J Vaccines Vaccin
Page 73 and 74:
Young Research ForumSession ChairPe
Page 75 and 76:
Humberto Hernandez et al., J Vaccin
Page 77 and 78:
Nisha Nair et al., J Vaccines Vacci
Page 79 and 80:
Leow Yee et al., J Vaccines Vaccin
Page 81 and 82:
Kaissar Tabynov et al., J Vaccines
Page 83 and 84:
Teena Mohan et al., J Vaccines Vacc
Page 85 and 86:
Track 5 & 95: Manufacturing, Produc
Page 87 and 88:
Graham Clarke, J Vaccines Vaccin 20
Page 89 and 90:
Obradovic Zarema et al., J Vaccines
Page 91 and 92:
Abdur Razzaque Sarker et al., J Vac
Page 93 and 94:
Omer Qutaiba B. Al-lela et al., J V
Page 95 and 96:
111 th OMICS Group Conference3 rd I
Page 97 and 98:
Regina Heidenreich et al., J Vaccin
Page 99 and 100:
Leow Y et al., J Vaccines Vaccin 20
Page 101 and 102:
Zafer Kurugol et al., J Vaccines Va
Page 103 and 104:
Ates Kara et al., J Vaccines Vaccin
Page 105 and 106:
Yurong Tan et al., J Vaccines Vacci
Page 107 and 108:
Deryabin P.N. et al., J Vaccines Va
Page 109 and 110:
Xiao-Yong Fan et al., J Vaccines Va
Page 111 and 112:
Byung Chul Kim et al., J Vaccines V
Page 113 and 114:
STS. Chitradevi et al., J Vaccines
Page 115 and 116:
Yan Liang et al., J Vaccines Vaccin
Page 117 and 118:
Page 119 and 120:
Afshineh Latifynia et al., J Vaccin
Page 121 and 122:
Hemanta Koley et al., J Vaccines Va
Page 123 and 124:
Aleksandar Masic et al., J Vaccines
Page 125 and 126:
Hassen Mamo, J Vaccines Vaccin 2013
Page 127 and 128:
Oladipo Aina et al., J Vaccines Vac
Page 129 and 130:
Aiswariya Chidambaram, J Vaccines V
Page 131 and 132:
Birhanu Hurisa et al., J Vaccines V
Page 133 and 134:
Ghaffarifar F et al., J Vaccines Va
Page 135 and 136:
Mathan Periasamy et al., J Vaccines
Page 137 and 138:
Rania Abdel Hay, J Vaccines Vaccin
Page 139 and 140:
Samuel Teshome, J Vaccines Vaccin 2
Page 141 and 142:
Page 143 and 144:
Birhanu Hurisa et al., J Vaccines V
Page 145 and 146:
Dhrubajyoti Nag, J Vaccines Vaccin
Page 147 and 148:
Belachew Etana et al., J Vaccines V
Page 149 and 150:
Fatemeh Ghaffarifar et al., J Vacci
Page 151 and 152:
Moustafa A.F. Abbas et al., J Vacci
Page 153 and 154:
Prerna Chaudhary, J Vaccines Vaccin
Page 155 and 156:
Sandeepkumar R. Chauhan et al., J V
Page 157 and 158:
Veronica Rainone et al., J Vaccines
Page 159 and 160:
Page 159
Page 161 and 162:
Previous111 th OMICS Group Conferen
Page 163 and 164:
PreviousWorld Congress and Expo onB
show all

Vaccines-2013 - OMICS Group

Create successful ePaper yourself

Delete template?

Save as template?